ARICI MARTINA

Vinarsky, V., Pagliari, S., Aldabash, B., Martino, F., Mazzotti, C., Jirakova, K., et al. (2025). YAP1 reactivation in cardiomyocytes following ECM remodelling contributes to the development of contractile force and sarcomere maturation. CELL DEATH DISCOVERY, 11(1) [10.1038/s41420-025-02793-2]. Dettaglio

Frosio, A., Marchese, P., Bertoli, G., Molla, D., Arici, M., Bartolucci, C., et al. (2025). Hypokalemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation. EUROPACE [10.1093/europace/euaf160]. Dettaglio

Arici, M., Hsu, S., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., et al. (2024). Selective SERCA2a activator as a candidate for chronic heart failure therapy. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-04874-9]. Dettaglio

Benzoni, P., Arici, M., Giannetti, F., Cospito, A., Prevostini, R., Volani, C., et al. (2024). Striatin knock out induces a gain of function of INa and impaired Ca2+ handling in mESC‐derived cardiomyocytes. ACTA PHYSIOLOGICA, 240(8 (August 2024)) [10.1111/apha.14160]. Dettaglio

Molla, D., Frosio, A., Bertoli, G., Piantoni, C., Arici, M., Bartolucci, C., et al. (2024). In-vitro studies of the NaV1.5 S805L Brugada mutation: The resting cell voltage is a critical element in determining the pathological or physiological phenotype of the current. Intervento presentato a: XXIV congress of the italian society of cardiovascular research, Imola, Italy [10.1016/j.vph.2024.107337]. Dettaglio